|
31
|
Product specific BE guideline |
Montelukast sodium Tablets_生體相等性試驗指導原則
|
2021-11-22 |
|
32
|
Product specific BE guideline |
Nebivolol hydrochloride tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
33
|
Product specific BE guideline |
Sitagliptin phosphate_Metformin HCl Tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
34
|
Product specific BE guideline |
Sultamicillin tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
35
|
Product specific BE guideline |
Tamsulosin PR Tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
36
|
Product specific BE guideline |
Sorafenib Tosylate Tablets-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
37
|
Product specific BE guideline |
Drospirenone/Ethinyl Estradiol Tablets-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
38
|
Product specific BE guideline |
Sunitinib Hard Capsules-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
39
|
Product specific BE guideline |
Temozolomide Capsules-學名藥生體相等性試驗指導原則
|
2022-12-28 |
|
40
|
Product specific BE guideline |
Raloxifene Tablets_學名藥生體相等性試驗指導原則
|
2025-01-20 |
